MARINE BIODIVERSITY AS A SOURCE OF CHEMICAL DIVERSITY

Total global biodiversity is estimated at between 3 and 500 x 10(6) species of prokaryote and eukaryote organisms spread across 70 or more phyla. the marine macrofauna alone are estimated between 0.5 and 30 x 10(6) species and represents a broader range of taxonomic diversity than that found in the terrestrial environment, which has been the traditional source of natural products. With a typical eukaryote possessing 50,000 genes, the global marine macrofauna are the source of 2.5 x 10(10) to 1.5 x 10(12) primary products and an associated extensive range of secondary products. However, only a few thousand novel compounds from marine organisms have been described. These compounds have proven unique in chemical and pharmacological terms but, as yet, not therapeutic agents have resulted. Given a broader drug discovery strategy, and facilitated by technological advances, it si predicted that the characterisation of marine chemical diversity will be accelerated. Strategies fro drug discovery from the virtually untapped chemical diversity of marine organisms are discussed. (C) 1994 Wiley-Liss, Inc.